Real-World tracking of lupus drug safety and impact
NCT ID NCT03370263
Summary
This study aimed to monitor the long-term safety and effectiveness of Benlysta injections for treating Systemic Lupus Erythematosus (SLE) in real-world medical practice. It followed over 1,500 patients for one year after they started treatment. The goal was to gather information on side effects, how well the drug controlled disease activity, and its impact on patients' daily lives to ensure the medicine is used safely and effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Hiroshima, 730-0001, Japan
Conditions
Explore the condition pages connected to this study.